Tavdro 40mg Injection
By Tavdro
Rx
1 Injection in a Vial

Composition
Drotaverine(40mg)

Manufacturer - Forgo Pharmaceuticals Pvt Ltd
Forgo Pharmaceuticals Private Limited, Plot No. 92, Industrial Area, Phase 1, Panchkula-134109, Haryana, India

Expires on or after
July, 2025

liver
Limited information is available on the safety of Tavdro 40mg Injection in individuals with liver disease. It is important to consult with your doctor regarding the use of this medication if you have liver issues. Your healthcare provider can provide personalized guidance based on your specific health condition.

kidney
Limited information is known about the use of Tavdro 40mg Injection in kidney disease patients. It is advised to consult your doctor before use.

alcohol
Consult your doctor when consuming alcohol with Tavdro 40mg Injection.

driving
Tavdro 40mg Injection may cause vertigo, affecting driving ability. Use caution when driving after taking Tavdro 40mg Injection.

pregnancy
Information about the safety of using Tavdro 40mg Injection during pregnancy is not provided. It is recommended to consult with your doctor before considering the use of this medication.

breastfeeding
It is better to consult your doctor before using Tavdro 40mg Injection during breastfeeding.
Habit Forming | No |
Chemical Class | Papaverine Derivatives |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Phosphodiesterase-IV inhibitors (Smooth Muscle Relaxant) |
₹71
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025